These findings suggest that urinary LRG1, in particular, holds promise as a non-invasive diagnostic tool for PAA, with potential applications in reducing diagnostic errors and improving patient outcomes. Here, LRG1 is linked to pulmonary artery-aorta diameter ratio measurement.